JNJ 62.56 -0.59 / Johnson & Johnson FDA | Benzinga

Tuesday, May 22, 2012

Prostate Cancer Companies Suffer When They Ignore Urologists (DNDN, EXEL, JNJ, MDVN, FDA, Markets, Trading Ideas / Tue, 11:47am)

Thursday, April 19, 2012

S&P: Bullish On Pharma ETFs Long-Term (ABT, AGN, Analyst Color, IHE, JNJ, Long Ideas, MRK, MRX, News, PFE, PPH, PRGO, QCOR, Sector ETFs, SPY, VHT, WPI, XLV, XPH, Short Ideas, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas, ETFs / Thu, 02:45pm)

Tuesday, March 27, 2012

FDA Approves INTELENCE Tablets for Treatment-Experienced Pediatric Patients with HIV-1 (JNJ, News, FDA / Tue, 08:06am)

Monday, March 26, 2012

UPDATE: Bayer's Xarelto Comparable to Standard Therapy; Blood Thinner Treats Blood Clots with Less Bleeding (JNJ, News, FDA / Mon, 09:04am)

Thursday, March 08, 2012

Will Johnson & Johnson Cure Cancer? (DNDN, Earnings, JNJ, MDVN, News, Guidance, Small Cap, FDA, Events, Trading Ideas / Thu, 01:57pm)

Monday, February 27, 2012

U.S. FDA Grants Priority Review for XARELTO to Reduce Secondary Cardiovascular Events in Patients with Acute (JNJ, News, FDA / Mon, 05:32pm)

Thursday, January 26, 2012

Benzinga's M&A Chatter for Thursday January 26, 2012 (AMGN, CELG, ELN, IDIX, ILMN, JNJ, Long Ideas, MITI, MRK, News, RHHBY, SGEN, Short Ideas, Rumors, FDA, M&A, After-Hours Center, Movers, Tech, Media, Trading Ideas / Thu, 07:24pm)

Tuesday, January 24, 2012

Johnson & Johnson Earnings Preview (Earnings, JNJ, News, Dividends, Previews, FDA, Pre-Market Outlook, Markets, Trading Ideas / Tue, 04:40am)

Friday, December 30, 2011

ETF Showdown: Fun With Pharma (ABT, AGN, AZN, HSP, JAZZ, JNJ, LLY, Long Ideas, MRK, MYL, News, PFE, PPH, Sector ETFs, SLXP, XPH, Short Ideas, New ETFs, FDA, After-Hours Center, Markets, Movers, Trading Ideas, ETFs / Fri, 05:10pm)

Tuesday, December 27, 2011

Will This Company's Drug Cure Your Allergies? (Earnings, JNJ, News, PFE, PRGO, TEVA, TGT, WAG, Guidance, FDA, Legal, Events / Tue, 01:32pm)

Thursday, December 08, 2011

Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech (JNJ, News, PCYC, Contracts, FDA / Thu, 05:08pm)

Friday, November 04, 2011

FDA Approves Bayer/J&J's Xarelto for Stroke Prevention (BAYRY, Earnings, JNJ, News, FDA / Fri, 08:21pm)

Saturday, September 24, 2011

Remicade Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis (JNJ, News, FDA, After-Hours Center / Sat, 10:37am)

Wednesday, September 14, 2011

Johnson & Johnson to Face Arkansas Trial Over Risperdal -Bloomberg (JNJ, News, FDA, Legal, After-Hours Center / Wed, 07:15pm)

Thursday, September 08, 2011

FDA Advisory Committee Recommends Approval of Johnson & Johnson Oral Anticoagulant (JNJ, News, FDA, After-Hours Center / Thu, 05:39pm)

Friday, July 01, 2011

UPDATE: Johnson & Johnson: FDA Approves XARELTO (JNJ, News, FDA / Fri, 03:14pm)

Tuesday, June 07, 2011

J&J's DACOGEN is Showing an Overall Survival Advantage (JNJ, News, FDA / Tue, 11:08am)

Friday, May 20, 2011

J&J Drug Edurant Is Approved For Treatment-Naive Hiv Patients -Bloomberg (JNJ, News, FDA / Fri, 11:06am)
Cordis Receives FDA Approval for EXOSEAL™ Vascular Closure Device (JNJ, News, FDA / Fri, 10:20am)

Monday, May 09, 2011

Study Findings Demonstrate Clinical Response with REMICADE in Pediatric Patients Who Have Not Responded to Conventional Therapy (JNJ) (JNJ, News, FDA / Mon, 04:35pm)

Friday, April 29, 2011

Centocor Ortho Biotech Products Voluntarily Withdraws NDA for Trabectedin (JNJ) (JNJ, News, ROC, FDA / Fri, 02:44pm)

Thursday, April 28, 2011

FDA Clears J&J's Abiraterone Acetate for Prostate Cancer -Bloomberg (JNJ) (JNJ, News, FDA / Thu, 02:26pm)

Wednesday, April 27, 2011

Tornier N.V. Rallies on Alleged Johnson & Johnson Takeover (TRNX) (BSX, IHI, JNJ, MDT, TMO, TRNX, Rumors, Small Cap Analysis, FDA, Legal, M&A, Trading Ideas / Wed, 07:46am)
J&J May Offer $21.3 Billion For Synthes (JNJ, News, PFE, Wall Street Journal, Rumors, FDA, M&A, Pre-Market Outlook, Intraday Update, Markets, Movers / Wed, 02:50am)

Monday, April 11, 2011

FDA Grants INVEGA Approval (JNJ) (JNJ, News, FDA / Mon, 08:05am)

Friday, March 11, 2011

Zings Of The day (JNJ, GS) (GS, JNJ, News, FDA, M&A / Fri, 04:58pm)

Wednesday, September 22, 2010

Johnson & Johnson, the FDA and a Phantom Recall (JNJ, News, FDA / Wed, 11:39am)

Friday, September 17, 2010

Benzinga's Top Pre-Market NASDAQ Gainers (CRXL, ALKS, CCME, RIMM) (ALKS, CCME, CRXL, JNJ, Long Ideas, News, RIMM, FDA, M&A, Pre-Market Outlook, Markets, Movers, Trading Ideas / Fri, 09:12am)

Wednesday, June 16, 2010

13 Drugs Facing FDA Approval Decisions (HGSI, HSP, JAV, JNJ, News, FDA, Markets / Wed, 08:43am)

Tuesday, May 04, 2010

FDA Gets Tough With Johnson & Johnson Over Drug Recall (JNJ) (JNJ, News, FDA, Intraday Update / Tue, 06:11pm)

Tuesday, January 19, 2010

Success For Johnson & Johnson’s (JNJ) Stelara (AMGN, JNJ, News, FDA, Markets / Tue, 01:48pm)

Monday, January 18, 2010

Johnson & Johnson (JNJ) Target Of FDA Wrath (JNJ, News, FDA, Markets / Mon, 12:14pm)

Wednesday, January 13, 2010

Vertex Pharma (VRTX) To File For Hepatitis Drug Approval (CNBC, JNJ, News, VRTX, Price Target, FDA, Markets, Analyst Ratings, Media / Wed, 05:14am)

Thursday, January 07, 2010

Experts To Re-Evaluate Use of Anaemia Drugs, (AMGN, JNJ) (AMGN, JNJ, News, FDA, Markets / Thu, 12:28pm)